Clinical Trials

Showing trials with last updates posted in 2022.

NCT02926222 | COMPLETED | PHASE2
119 participants

Regorafenib in Relapsed Glioblastoma

Study Type:
INTERVENTIONAL
Last Updated:
2022-09-09
Start Date:
2015-11-30
Completion:
2017-07-31
Conditions
  • Glioblastoma Multiforme
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page